Skip to main content

Day: January 13, 2023

TransUnion Announces Earnings Release Date for Fourth Quarter 2022 Results

CHICAGO, Jan. 13, 2023 (GLOBE NEWSWIRE) — TransUnion (NYSE: TRU) will publish its financial results for the fourth quarter ended December 31, 2022, in a press release to be issued by 6:00 a.m. Central Time (CT) on Tuesday, February 14, 2023. The company will hold a conference call on the same day at 8:30 a.m. Central Time (CT) to discuss its financial results. The press release and a live webcast of the earnings conference call will be available on the TransUnion Investor Relations website at http://www.transunion.com/tru. About TransUnion (NYSE: TRU) TransUnion is a global information and insights company that makes trust possible in the modern economy. We do this by providing an actionable picture of each person so they can be reliably represented in the marketplace. As a result, businesses and consumers can transact with confidence...

Continue reading

Unity Bancorp Reports Quarterly Earnings of $10.0 Million and Full Year Earnings of $38.5 Million

CLINTON, N.J., Jan. 13, 2023 (GLOBE NEWSWIRE) — Unity Bancorp, Inc. (NASDAQ: UNTY), parent company of Unity Bank, reported net income of $10.0 million, or $0.93 per diluted share, for the quarter ended December 31, 2022, compared to net income of $9.7 million, or $0.93 per diluted share for the prior year’s fourth quarter. This represents a 2.2% increase in net income and net income per diluted share remains flat. For the twelve months ended December 31, 2022, Unity reported net income of $38.5 million, or $3.59 per diluted share, compared to $36.1 million or $3.43 per diluted share for the prior year. This represents a 6.5% increase in net income and a 4.7% increase in net income per diluted share. James A. Hughes, President and CEO, commented on the financial results: “It is with great pleasure that we announce another record...

Continue reading

Hepsor N57 OÜ, Hepsor AS group company, signed 3.1 million euro loan agreement for financing the construction of Lilleküla Kodud project

Hepsor N57 OÜ, Hepsor AS group company, and LHV Pank OÜ signed 3.1 million loan agreement on 13 January 2023. The purpose of the three-year loan is to finance the construction of Lilleküla Kodud development project. The development project has 26 apartments of different sizes, from compact one-room apartments to spacious four-room apartments with large terraces. The construction and sales of Lilleküla Kodud project that started in December 2022 will be completed at the end of 2023. According to Henri Laks, member of the Management Board, the project is special because of the limited number of new developments in the area, which is in high demand and highly valued by customers. „The size of the building also makes the project special – a building with only 26 apartments in a cozy garden suburb is like a unique boutique product. We...

Continue reading

Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Shareholders Vote for the Proposed Arrangement With Pan American and Agnico Eagle

TORONTO, Jan. 13, 2023 (GLOBE NEWSWIRE) — Yamana Gold Inc. (TSX:YRI; NYSE:AUY; LSE:AUY) (“Yamana” or the “Company”) is pleased to announce that the Company has received positive recommendations from both Institutional Shareholder Services (“ISS”) and Glass, Lewis & Co. LLC (“Glass Lewis”) in support of the previously announced arrangement involving the acquisition by Pan American Silver Corp. (“Pan American”) of all of the issued and outstanding common shares of the Company following the sale by Yamana of its Canadian assets, including certain subsidiaries and partnerships which hold Yamana’s interests in the Canadian Malartic mine, to Agnico Eagle Mines Limited (“Agnico Eagle”), all by way of a plan of arrangement under the Canada Business Corporations Act (the “Proposed Transaction”). ISS and Glass Lewis are leading independent,...

Continue reading

Alvotech and Fuji Pharma Expand Partnership Adding a New Biosimilar Candidate

REYKJAVIK, Iceland and TOKYO, Jan. 13, 2023 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Japanese pharmaceutical company Fuji Pharma Co., Ltd. (“Fuji”, Tokyo Stock Exchange: 4554) have decided to expand their existing exclusive commercialization partnership covering Japan, by adding a new undisclosed biosimilar candidate. “We are pleased to expand our successful collaboration with Fuji. Just recently, we announced the submission of an application for marketing approval in Japan for the first biosimilar candidate developed under our partnership,” said Robert Wessman, Founder, CEO and Chairman of Alvotech. “This extension to our existing agreement aligns with our common objective, which is to increase patient...

Continue reading

Alvotech and Fuji Pharma Expand Partnership Adding a New Biosimilar Candidate

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Japanese pharmaceutical company Fuji Pharma Co., Ltd. (“Fuji”, Tokyo Stock Exchange: 4554) have decided to expand their existing exclusive commercialization partnership covering Japan, by adding a new undisclosed biosimilar candidate. “We are pleased to expand our successful collaboration with Fuji. Just recently, we announced the submission of an application for marketing approval in Japan for the first biosimilar candidate developed under our partnership,” said Robert Wessman, Founder, CEO and Chairman of Alvotech. “This extension to our existing agreement aligns with our common objective, which is to increase patient access to vital biologic medicines in the growing Japanese market,” said...

Continue reading

Himax Technologies, Inc. Schedules Fourth Quarter and Full Year 2022 Financial Results Conference Call on Thursday, February 9, 2023 at 8:00 AM EST

TAINAN, Taiwan, Jan. 13, 2023 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, today announced that it will hold a conference call with investors and analysts on Thursday, February 9 at 8:00 a.m. US Eastern Standard Time and 9:00 p.m. Taiwan Time to discuss the Company’s fourth quarter and full year 2022 financial results.HIMAX TECHNOLOGIES FOURTH QUARTER AND FULL YEAR 2022 EARNINGS CONFERENCE CALLDATE: Thursday, February 9, 2023TIME: U.S.       8:00 a.m. EST  Taiwan  9:00 p.m.WEBCAST: https://edge.media-server.com/mmc/p/959exv4hPHONE REGISTRATION: https://register.vevent.com/register/BIcfaa1824de1d44e9a188f089fb44b7eaIf you choose to attend by phone, you need to register...

Continue reading

Reliq Health Technologies, Inc. Announces Eight New US Contracts in CA, NV and TX

HAMILTON, Ontario, Jan. 13, 2023 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today announced that it has signed new contracts with three multi-physician clinics in North Texas and five physician practices that provide care to patients in California and Nevada. The contracts are expected to add at least 5,000 new patients to Reliq’s iUGO Care platform over the next two quarters. “We are very pleased to be continuing to expand our presence in California, Nevada and Texas,” said Dr. Lisa Crossley, CEO at Reliq Health Technologies, Inc. “Reliq continues to attract new clients through referrals from existing customers...

Continue reading

Strategic review of SalMar’s indirect holding in Frøy ASA

Based on incoming interest regarding Frøy ASA (OSE:FROY) (“Frøy”), NTS ASA (“NTS”), a wholly owned subsidiary of SalMar ASA (“SalMar”), has decided to explore strategic alternatives in Frøy with the aim of maximizing value for its shareholders. NTS currently holds 62,269,112 shares in Frøy representing approximately 72.11% of the shares and votes in Frøy. NTS has engaged DNB Markets as financial advisor and Advokatfirmaet BAHR AS as legal adviser to assist in the strategic review. Frøy is a leading integrated provider of aqua services to Norwegian salmon farmers. With a team of more than 800 aqua service specialists and a modern fleet of more than 80 vessels, Frøy offers a wide range of infrastructure services to salmon farmers. The service offering includes transport of fish, sorting, counting, cleaning of nets, treatment for diseases...

Continue reading

Proposals by the Nomination Board to the Annual General Meeting 2023 of Suominen

Laura Remes Laura RemesSuominen Corporation’s stock exchange release on January 13, 2023 at 9:30 a.m. EET Proposal on the number of the members, on the composition, and on the Chair of the Board of Directors The Nomination Board of Suominen Corporation’s shareholders proposes to the Annual General Meeting that the number of Board members remains unchanged and would be six (6). The Nomination Board proposes to the Annual General Meeting that Andreas Ahlström, Aaron Barsness, Björn Borgman, Jaakko Eskola and Nina Linander would be re-elected as members of the Board of Directors and that Laura Remes would be elected as a new member of the Board of Directors. Out of the current Board members, Laura Raitio has informed that she is no longer available as a candidate for the Board of Directors. Laura Remes (born 1980, M.Sc. (Technology),...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.